title: Persistence of protein oxidation products and plasma antioxidants in juvenile idiopathic arthritis. A one-year follow-up study.
abstract: OBJECTIVE
  Plasma protein oxidation products and blood antioxidants, like superoxide dismutase (SOD), glutathione peroxidase (GPx) and total antioxidant status (TAS) were investigated in children with juvenile idiopathic arthritis (JIA) in a year follow-up study.
  
  
  METHODS
  Carbonyl group content within plasma proteins, activity of red blood cell SOD and GPx, as well as the blood TAS level were determined in 14 children with JIA twice, namely at the admission to the hospital (Time 0 = T0) and then after a year of treatment (Time 1 = T1).
  
  
  RESULTS
  An increased level of plasma protein carbonyls was observed in both assessments (T0 and T1) as compared to control. However there was no significant difference in plasma carbonyls level between the initial (T0) and final (T1) examination of the patients. Similarly, SOD activity was higher in children with JIA as compared to control subjects and did not change significantly after a year of follow-up. Red blood cell GPx activity remained within the normal range throughout the study. Interestingly, the blood TAS level was initially comparable to control and rose significantly after the year of treatment.
  
  
  CONCLUSIONS
  A level of plasma protein oxidation products remains significantly higher in children with JIA as compared to healthy subjects. The lack of accumulation of plasma protein carbonyls may result from efficient proteolysis in childhood and/or adaptive increase of the blood TAS level in the course of effective anti-inflammatory therapy. Analysis of plasma oxidative stress markers and antioxidant potential of the blood might be helpful in monitoring the clinical treatment of children suffering from JIA.
authors.affiliation: Department of Pediatrics, Pediatric Gastroenterology and Oncology, Medical University of Gdańsk, Gdańsk, Poland.
authors.forename: J
authors.initials: J
authors.lastname: Renke
authors.forename: A
authors.initials: A
authors.lastname: Szlagatys
authors.forename: R
authors.initials: R
authors.lastname: Hansdorfer-Korzon
authors.forename: M
authors.initials: M
authors.lastname: Szumera
authors.forename: B
authors.initials: B
authors.lastname: Kamińska
authors.forename: N
authors.initials: N
authors.lastname: Knap
authors.forename: S
authors.initials: S
authors.lastname: Popadiuk
authors.forename: A
authors.initials: A
authors.lastname: Szarszewski
authors.forename: M
authors.initials: M
authors.lastname: Woźniak
mesh_terms: D000293:Adolescent; D001171:Arthritis, Juvenile / Q000097:blood* / Q000188:drug therapy; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D005979:Glutathione Peroxidase / Q000097:blood* / Q000187:drug effects; D006801:Humans; D008297:Male; D050050:Protein Carbonylation / Q000187:drug effects; D013482:Superoxide Dismutase / Q000097:blood* / Q000187:drug effects
chemical_list: D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase